Amniotic membrane transplantation: Current indications in a tertiary eye hospital of eastern Nepal.

INTRODUCTION Amniotic membrane has unique properties that can be helpful to treat different ocular surface diseases. OBJECTIVES To report our experience with 100% glycerol preserved amniotic membrane at 4°C and fresh amniotic membrane transplantation (AMT) with and without limbal graft for ocular surface reconstruction. MATERIALS AND METHODS Retrospective case study of 211 eyes of 211 patients was conducted at Biratnagar Eye Hospital from June 2008 to March 2014. The cases were evaluated in terms of demographic parameters, preoperative diagnosis and the type of surgery performed. RESULTS The most common indication for surgery was Pterygium (90 eyes, 42.65%), followed by symblepharon (57 eyes, 27.01%), chemical injury (35 eyes, 16.58%), socket reconstruction (9 eyes, 4.26%), shield ulcer (6 eyes, 2.84%), PED (4 eyes, 1.89%), Steven Jonson's syndrome (5 eyes, 2.36%), dry Eye (2 eyes, 0.94%), Corneal Degeneration (2 eyes, 0.94%), bullous keratopathy (1 eye, 0.47%). The mean age was 28.12 ±17.2 years (age range 3-78 years). More men (161, 76.30%) underwent surgery than women (50 eyes, 23.69%). Symblepharon (24 eyes, 36.36%) was the major cause of surgery in pediatric group. The mean follow-up was 7 months (range 2-36, months). Resurgery was needed in (18 eyes, 8.53%) of which symblepharon (7eyes, 39%) was the major cause. AMT was done in 189 (89.57%) eyes and AMT with conjunctival limbal graft was done in 22(10.42 %) cases. Infectious, inflammatory, or allergic reactions were not encountered in any patient. CONCLUSION All patient experienced increased ocular comfort with anatomical restoration of corneal and conjunctival surfaces. AMT alone or in combination with limbal graft aids in ocular surface reconstruction.

[1]  A. Hopkinson,et al.  Augmented Dried versus Cryopreserved Amniotic Membrane as an Ocular Surface Dressing , 2013, PLoS ONE.

[2]  L. Hirst Recurrence and complications after 1,000 surgeries using pterygium extended removal followed by extended conjunctival transplant. , 2012, Ophthalmology.

[3]  M. van Griensven,et al.  Impact of human amniotic membrane preparation on release of angiogenic factors , 2009, Journal of tissue engineering and regenerative medicine.

[4]  A. Kheirkhah,et al.  Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2009, Survey of ophthalmology.

[5]  Y. Akova,et al.  Comparison of Conjunctival Autograft With Amniotic Membrane Transplantation for Pterygium Surgery: Surgical and Cosmetic Outcome , 2007, Cornea.

[6]  M. Shin,et al.  Amniotic Membrane Transplantation in the Management of Shield Ulcers of Vernal Keratoconjunctivitis , 2004 .

[7]  H. Dua,et al.  The amniotic membrane in ophthalmology. , 2004, Survey of ophthalmology.

[8]  M. Lee-Wing Amniotic membrane for repair of exposed hydroxyapatite orbital implant. , 2003, Ophthalmic plastic and reconstructive surgery.

[9]  B. Seitz,et al.  Corneal calcification after amniotic membrane transplantation , 2003, The British journal of ophthalmology.

[10]  E. Tedeschi-Reiner,et al.  Amniotic membrane transplantation for ocular surface reconstruction. , 2002, Collegium antropologicum.

[11]  J. Stewart,et al.  Amniotic Membrane Graft in the Surgical Management of Cryptophthalmos , 2002, Ophthalmic plastic and reconstructive surgery.

[12]  J. Baum Amniotic Membrane Transplantation: Why is it Effective? , 2002 .

[13]  N. Sharma,et al.  Infection after use of nonpreserved human amniotic membrane for the reconstruction of the ocular surface. , 2001, Cornea.

[14]  L. See,et al.  Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment , 2000, The British journal of ophthalmology.

[15]  C. Lohmann,et al.  Hypopyon after repeated transplantation of human amniotic membrane onto the corneal surface. , 2000, Ophthalmology.

[16]  R. J. Mack,et al.  Amniotic membrane transplantation for acute chemical or thermal burns. , 2000, Ophthalmology.

[17]  J. Reece,et al.  Efficacy and kinetics of glycerol inactivation of HIV‐1 in split skin grafts , 2000, Journal of medical virology.

[18]  M. Haberal,et al.  Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing. , 1999, Burns : journal of the International Society for Burn Injuries.

[19]  H. Dua Amniotic membrane transplantation , 1999, The British journal of ophthalmology.

[20]  E. Middelkoop,et al.  Microbiological evaluation of glycerolized cadaveric donor skin. , 1998, Transplantation.

[21]  S. Tseng,et al.  Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. , 1998, Archives of ophthalmology.

[22]  S. Tseng,et al.  Amniotic membrane transplantation for conjunctival surface reconstruction. , 1997, American journal of ophthalmology.

[23]  S. Macneil,et al.  Effect of glycerol on intracellular virus survival: implications for the clinical use of glycerol-preserved cadaver skin. , 1995, Burns : journal of the International Society for Burn Injuries.

[24]  S. I. Brown,et al.  Characterization and inhibition of corneal collagenase. , 1971, Investigative Ophthalmology.

[25]  C. Dohlman,et al.  Collagenase in Corneal Ulcerations , 1969 .

[26]  C. Dohlman,et al.  Collagenase in the cornea. , 1969, Experimental eye research.

[27]  G. Bourne The microscopic anatomy of the human amnion and chorion. , 1960, American journal of obstetrics and gynecology.

[28]  A. Sorsby,et al.  FURTHER EXPERIENCE WITH AMNIOTIC MEMBRANE GRAFTS IN CAUSTIC BURNS OF THE EYE* , 1947, British Journal of Ophthalmology.

[29]  A. Sorsby,et al.  AMNIOTIC MEMBRANE GRAFTS IN CAUSTIC BURNS OF THE EYE* , 1946, The British journal of ophthalmology.

[30]  A. D. Rötth PLASTIC REPAIR OF CONJUNCTIVAL DEFECTS WITH FETAL MEMBRANES , 1940 .